SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 69 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130 | -33.7% | 18,270 | -29.9% | 0.00% | – |
| Q2 2023 | $196 | -80.4% | 26,051 | +14453.6% | 0.00% | – |
| Q2 2022 | $1,000 | -99.6% | 179 | -99.1% | 0.00% | – |
| Q1 2022 | $257,000 | -48.1% | 19,966 | +0.2% | 0.00% | – |
| Q4 2021 | $495,000 | -25.0% | 19,924 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $660,000 | -2.1% | 19,986 | -14.3% | 0.00% | 0.0% |
| Q2 2021 | $674,000 | -42.4% | 23,311 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $1,170,000 | +4.4% | 23,100 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,121,000 | +204.6% | 23,100 | +11.1% | 0.00% | – |
| Q3 2020 | $368,000 | -2.9% | 20,800 | 0.0% | 0.00% | – |
| Q2 2020 | $379,000 | +138.4% | 20,800 | +58.8% | 0.00% | – |
| Q1 2020 | $159,000 | -8.1% | 13,100 | 0.0% | 0.00% | – |
| Q4 2019 | $173,000 | +47.9% | 13,100 | 0.0% | 0.00% | – |
| Q3 2019 | $117,000 | -43.8% | 13,100 | 0.0% | 0.00% | – |
| Q2 2019 | $208,000 | +73.3% | 13,100 | +104.7% | 0.00% | – |
| Q1 2019 | $120,000 | -18.4% | 6,400 | 0.0% | 0.00% | – |
| Q4 2018 | $147,000 | – | 6,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |